Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

75% of Doctors Support Travel Ban from West Africa According to SERMO Poll

Physicians are concerned about the CDC's and Department of Homeland Security's Ability to Track and Screen Ebola Patients within the United States

Sermo logo. (PRNewsFoto/WorldOne) (PRNewsFoto/WORLDONE)

News provided by

SERMO

Oct 13, 2014, 11:15 ET

Share this article

Share toX

Share this article

Share toX

BOSTON, Oct. 13, 2014 /PRNewswire/ -- SERMO, the leading social network of fully verified, licensed physicians in the U.S., announced today the results of recent polling of the SERMO physician community about the Ebola epidemic and its implications for the United States.

When asked if they believe all travel from West Africa should be halted to the US, 75% of the respondents chose "Yes." The poll questions also highlight concerns many physicians have about the U.S. preparedness level of the healthcare system to handle Ebola.

Continue Reading

The SERMO community of over 270,000 doctors is actively discussing the latest developments in the Ebola crisis on their Infectious Disease Hub. The core issue is preparedness from the perspective of an already stressed frontline medical infrastructure.  Public health preparedness is one side of the story, and some question CDC's preparedness.  

But from the perspective of medical preparedness, the country's medical community has been clear: they do not feel prepared, and they need the federal government to listen to that concern.  Dallas is an example, but there will likely be others unless a change in screening protocols is adopted that go beyond simply checking temperatures at a few Ports of Entry. Some feel a better solution is to deny granting access to non-US citizens from the Ebola-affected areas of Africa through the State Department's Visa granting process until true epidemic containment has been achieved.

Over 3000 doctors joined the conversation, and 1,300 of our SERMO physicians participated in our poll and provided some eyebrow-raising opinions:

  • When asked if they feel the Department of Homeland Security is adequately screening inbound passengers from Ebola-affected areas, 91% said "No."
  • When asked if they believe the US Department of State is adequately sharing information regarding the Visa granting process and the specific location of where travelers are arriving from in West Africa, 90% answered "No."
  • When asked if they believe the experience of Dallas will significantly alter our medical preparedness writ large in America, 56% responded "No."

In a prior poll focusing on preparedness and the logic of focusing on contact tracing (tracking down everyone a patient has had contact with), over 370 physicians spoke up:

  • When asked how confident they are in the CDC's ability to effectively trace back contacts Ebola patients might have had with other people, 57% did not feel confident (37% said "not very confident" and another 20% said "not confident at all").
  • When asked if they had been in conversation about preparedness protocols regarding Ebola, 32% said "no one" and 31% said they'd "self-educated to prepare."
  • When asked where they are getting their guidance and reliable information regarding Ebola, 58% cited the CDC and 52% cited their peers on SERMO.

A SERMO member and contributor, Vice President of Ascel Bio and an infectious disease forecaster, Dr. James Wilson, MD, commented on the Dallas Ebola situation, "Dallas is giving the entire world a form of proof of just how infectious Ebola is. It's important to note the virus introduced to Dallas has likely mutated well beyond the initially disclosed 'hundreds of mutations.' So, pay attention people; Dallas has a mutated Ebola virus in the middle of its urban medical infrastructure, and yet here at Day 18, we have only one contact (a nurse) become symptomatic.  None of the family members have become symptomatic.  This is a key observation since the incubation period of Ebola is typically 7 to 10 days."

"The results of our latest survey show some eye-opening results," said Peter Kirk, CEO of SERMO. "With the recent case of the Dallas patient arriving from Liberia and reports of a nurse in Spain testing positive for the virus, the concern over Ebola is expanding globally. The discussion and survey results on SERMO reflect considerable anxiety within the US healthcare community as to the gaps in health screening and the risk posed by allowing travelers to come from West Africa. Physicians are speaking out...  We should listen."

For more information about the recent developments in the Ebola crisis, visit the SERMO blog at http://blog.sermo.com.  

About SERMO

SERMO is the United States' leading social network for doctors. Founded in 2005, SERMO's mission is to provide physicians with a safe, private and trusted platform for free and open discussions.

SERMO is a doctors' 'lounge' where doctors candidly share their true feelings about their profession and lives, but it's also a place where doctors learn from one another by asking each other real life questions, advice and second opinions about medicine.

Over the course of a decade, doctors have built an important medical knowledge bank within SERMO by virtue of those questions and answers.

With over 270,000 verified U.S. physicians from 96 specialties and subspecialties, representing 40 percent of the American medical community, the doctors-only member base closely aligns with national physician demographics, as reported by the AMA.  SERMO harnesses the collective wisdom of physicians, enabling medical crowdsourcing, knowledge sharing and thus the advancement of medicine.

SERMO is the place for real life medicine. It's the meeting of medical minds and hearts.

About SERMO Physician Polls

SERMO posts a poll with a fresh, topical question daily or weekly. Each member can vote once. Questions are generated by the SERMO Community Team, sometimes in coordination with members from the SERMO advisory team. The Community Team processes the results and usually segments responses by specialty. Polls are often posted in the SERMO blog, which is a way for physicians' opinions to be heard about the medical issues of the day.

Who participates in SERMO Polls?

Each poll can receive up to 3,000 votes. Polls are open to all members of the community.  We ask anything from when was your last physical to how do you feel about maintenance of certification courses.  Our polls are one of the most popular areas of our site, they spark plenty of healthy debate and enable doctors to have a voice on important issues. 

To learn more about SERMO, visit http://www.SERMO.com.

Photo - http://photos.prnewswire.com/prnh/20141013/151722-INFO

Logo - http://photos.prnewswire.com/prnh/20140410/CG02301LOGO-b

SOURCE SERMO

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.